https://www.selleckchem.com/pr....oducts/dansylcadaver
Further, the management of anticoagulation and thrombolysis is challenging in patients where an attendant bleeding risk exists. Concurrent aortic and venous thromboses are rare. This finding in COVID-19 cases, who were both critically ill patients, likely reflects the strongly thrombogenic nature of this illness which ultimately contributed to poor outcomes. The absence of deep vein thrombosis or a potential systemic source of embolism suggests in situ thrombosis. Further, the management of anticoagulation
Synes godt om
Kommentar
Del
